OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Coronavirus Proteins as Ion Channels: Current and Potential Research
Conor McClenaghan, Alex Hanson, Sun Joo Lee, et al.
Frontiers in Immunology (2020) Vol. 11
Open Access | Times Cited: 71

Showing 1-25 of 71 citing articles:

Structural biology of SARS-CoV-2: open the door for novel therapies
Weizhu Yan, Yanhui Zheng, Xiao‐Tao Zeng, et al.
Signal Transduction and Targeted Therapy (2022) Vol. 7, Iss. 1
Open Access | Times Cited: 250

The glycosylation in SARS-CoV-2 and its receptor ACE2
Yanqiu Gong, Suideng Qin, Lunzhi Dai, et al.
Signal Transduction and Targeted Therapy (2021) Vol. 6, Iss. 1
Open Access | Times Cited: 174

Understanding the Role of SARS-CoV-2 ORF3a in Viral Pathogenesis and COVID-19
Jiantao Zhang, Amara Ejikemeuwa, Volodymyr Gerzanich, et al.
Frontiers in Microbiology (2022) Vol. 13
Open Access | Times Cited: 110

The SARS-CoV-2 accessory protein Orf3a is not an ion channel, but does interact with trafficking proteins
Alexandria N. Miller, Patrick R. Houlihan, Ella Matamala, et al.
eLife (2023) Vol. 12
Open Access | Times Cited: 50

Cryo-EM structure of the SARS-CoV-2 3a ion channel in lipid nanodiscs
David M. Kern, Ben Sorum, Sonali S. Mali, et al.
bioRxiv (Cold Spring Harbor Laboratory) (2020)
Open Access | Times Cited: 112

Characterization of the SARS‐CoV‐2 E Protein: Sequence, Structure, Viroporin, and Inhibitors
Yipeng Cao, Rui Yang, Imshik Lee, et al.
Protein Science (2021) Vol. 30, Iss. 6, pp. 1114-1130
Open Access | Times Cited: 103

Identification of Potent and Safe Antiviral Therapeutic Candidates Against SARS-CoV-2
Xia Xiao, Conghui Wang, De Chang, et al.
Frontiers in Immunology (2020) Vol. 11
Open Access | Times Cited: 78

The envelope protein of SARS‐CoV‐2 increases intra‐Golgi pH and forms a cation channel that is regulated by pH
David Cabrera-García, Ramsey Bekdash, Geoffrey W. Abbott, et al.
The Journal of Physiology (2021) Vol. 599, Iss. 11, pp. 2851-2868
Open Access | Times Cited: 66

A comprehensive SARS-CoV-2 and COVID-19 review, Part 1: Intracellular overdrive for SARS-CoV-2 infection
David A. Jamison, S Narayanan, Nídia S. Trovão, et al.
European Journal of Human Genetics (2022) Vol. 30, Iss. 8, pp. 889-898
Open Access | Times Cited: 66

Review of COVID-19 Vaccines Approved in the United States of America for Emergency Use
Deepa Vasireddy, Paavani Atluri, Srikrishna V Malayala, et al.
Journal of Clinical Medicine Research (2021) Vol. 13, Iss. 4, pp. 204-213
Open Access | Times Cited: 57

Viroporins: Structure, function, and their role in the life cycle of SARS-CoV-2
Ulrike Breitinger, Noha S. Farag, Heinrich Sticht, et al.
The International Journal of Biochemistry & Cell Biology (2022) Vol. 145, pp. 106185-106185
Open Access | Times Cited: 44

The Role of the Tyrosine-Based Sorting Signals of the ORF3a Protein of SARS-CoV-2 in Intracellular Trafficking and Pathogenesis
Edward B. Stephens, Dušan Kunec, Wyatt Henke, et al.
Viruses (2025) Vol. 17, Iss. 4, pp. 522-522
Open Access | Times Cited: 1

pH- and Calcium-Dependent Aromatic Network in the SARS-CoV-2 Envelope Protein
João Medeiros‐Silva, Noah H. Somberg, Harrison K. Wang, et al.
Journal of the American Chemical Society (2022) Vol. 144, Iss. 15, pp. 6839-6850
Open Access | Times Cited: 36

SARS-CoV-2 ORF3a Protein as a Therapeutic Target against COVID-19 and Long-Term Post-Infection Effects
Jiantao Zhang, Kellie Hom, Chen‐Yu Zhang, et al.
Pathogens (2024) Vol. 13, Iss. 1, pp. 75-75
Open Access | Times Cited: 7

Electrophysiological properties and structural prediction of the SARS-CoV-2 viroprotein E
Salvatore Antonio Maria Cubisino, Stefan Milenkovic, Stefano Conti Nibali, et al.
Frontiers in Molecular Biosciences (2024) Vol. 11
Open Access | Times Cited: 7

Genome-Wide Characterization of SARS-CoV-2 Cytopathogenic Proteins in the Search of Antiviral Targets
Jiantao Zhang, Qi Li, Ruth S. Cruz Cosme, et al.
mBio (2022) Vol. 13, Iss. 1
Open Access | Times Cited: 27

Probing effects of the SARS-CoV-2 E protein on membrane curvature and intracellular calcium
Aujan Mehregan, Sergio Pérez-Conesa, Yuxuan Zhuang, et al.
Biochimica et Biophysica Acta (BBA) - Biomembranes (2022) Vol. 1864, Iss. 10, pp. 183994-183994
Open Access | Times Cited: 22

Distinct motifs in the E protein are required for SARS-CoV-2 virus particle formation and lysosomal deacidification in host cells
Koya Miura, Youichi Suzuki, Kotaro Ishida, et al.
Journal of Virology (2023) Vol. 97, Iss. 10
Open Access | Times Cited: 13

Endoplasmic reticulum-associated SARS-CoV-2 ORF3a elicits heightened cytopathic effects despite robust ER-associated degradation
Jiantao Zhang, Ruth Cruz‐Cosme, Chen‐Yu Zhang, et al.
mBio (2023) Vol. 15, Iss. 1
Open Access | Times Cited: 13

COVID-19, Cation Dysmetabolism, Sialic Acid, CD147, ACE2, Viroporins, Hepcidin and Ferroptosis: A Possible Unifying Hypothesis
Attilio Cavezzi, Roberto Menicagli, Emidio Troiani, et al.
F1000Research (2022) Vol. 11, pp. 102-102
Open Access | Times Cited: 19

How many SARS-CoV-2 “viroporins” are really ion channels?
Neil L. Harrison, Geoffrey W. Abbott, Martina Gentzsch, et al.
Communications Biology (2022) Vol. 5, Iss. 1
Open Access | Times Cited: 17

Subcellular localization of SARS-CoV-2 E and 3a proteins along the secretory pathway
Joshua J. Hinkle, Kathleen A. Trychta, Emily S. Wires, et al.
Journal of Molecular Histology (2025) Vol. 56, Iss. 2
Open Access

Unification and extensive diversification of M/Orf3-related ion channel proteins in coronaviruses and other nidoviruses
Yongjun Tan, Theresa Schneider, Prakash Shukla, et al.
Virus Evolution (2021) Vol. 7, Iss. 1
Open Access | Times Cited: 23

Blockers of the SARS-CoV-2 3a Channel Identified by Targeted Drug Repurposing
Prabhat Pratap Singh Tomar, Miriam Krugliak, Isaiah T. Arkin
Viruses (2021) Vol. 13, Iss. 3, pp. 532-532
Open Access | Times Cited: 23

Page 1 - Next Page

Scroll to top